Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Endocrinology · Apparent Cortisone Reductase Deficiency

The Biology of ACRD: Impaired Hormone Conversion

At a Glance

Apparent cortisone reductase deficiency occurs when HSD11B1 or H6PD gene changes impair conversion of cortisone into active cortisol. Fast cortisol clearance raises ACTH, driving adrenal androgen excess; a 24-hour urine steroid profile helps support the diagnosis.

To understand Apparent Cortisone Reductase Deficiency (ACRD), it helps to think of the body’s hormone system as a recycling center. In a typical person, the body does not just make cortisol and throw it away; it converts inactive cortisone back into active cortisol when needed [1]. ACRD is what happens when this conversion process is impaired.

The Impaired Conversion Loop

The conversion of cortisone to cortisol is handled by an enzyme called 11β-HSD1. For this enzyme to do its job, it needs a constant supply of energy (a cofactor called NADPH), which is provided by a second enzyme called H6PD [1].

ACRD occurs because of a genetic mutation in either of these two parts:

  • HSD11B1 mutations: The enzyme itself is defective [1].
  • H6PD mutations: The “generator” is defective, so the enzyme does not have the NADPH it needs to run [1].

Because the body cannot efficiently convert cortisone back to cortisol, it loses active cortisol much faster than normal—a process called increased cortisol clearance [2].

Why This Leads to High Androgens

When the brain senses that cortisol is being cleared too fast, it releases a signal called ACTH (adrenocorticotropic hormone) to tell the adrenal glands to work harder to maintain normal cortisol levels [1].

The adrenal glands respond by going into overdrive (adrenocortical hyperactivity). While they successfully pump out more cortisol to keep up, they also produce high amounts of “byproducts”—specifically, androgens (such as testosterone) and 17-hydroxyprogesterone (17-OHP) [1][2]. It is these excess androgens that cause the early hair growth in children and irregular cycles or skin issues in adult women [2].

It’s important to clarify that having ACRD does not necessarily mean your body cannot make cortisol at all (unlike untreated classic adrenal insufficiency). You are usually making it, but clearing it away too quickly.

Differentiating ACRD from Other Conditions

Because ACRD is rare and causes high androgens, it is frequently confused with more common conditions. Doctors look for specific biological clues to tell them apart.

Feature ACRD Non-classic CAH (NCCAH) PCOS
Primary Biological Glitch Impaired conversion of inactive cortisone to active cortisol [1]. Failure to build cortisol from scratch (usually 21-hydroxylase deficiency) [3]. Complex hormonal imbalance often involving insulin and the ovaries [4].
Key Lab Marker Markedly low ratio of cortisol metabolites to cortisone metabolites in a 24-hr urine test [2]. Very high 17-OHP (especially after a stimulation test); specific genetic markers (CYP21A2) [5]. High androgens with specific ovarian features or irregular ovulation [6].
Cortisol “Fingerprint” Cortisol is made but cleared away too quickly [2]. Cortisol production is physically blocked at the assembly line [3]. Cortisol production and clearance are usually normal [7].

Note: A person can have both PCOS and an adrenal disorder, and they are diagnosed using a combination of clinical signs and lab tests.

A Key Test: The Urinary Steroid Profile

Because blood tests for ACRD can be misleading (for example, 17-OHP can be high in both ACRD and NCCAH), a key specialized test to support an ACRD diagnosis is a 24-hour urinary steroid profile using a technology called GC-MS or LC-MS/MS [2][8].

This test looks at the ratio of THF and 5α-THF (or allo-THF) (cortisol leftovers) to THE (cortisone leftovers). In a healthy person, this ratio is higher (often reported around 0.7 to 1.2, depending on the lab). In someone with ACRD, the ratio is drastically lower—sometimes reported in case studies as low as 0.021—because the body isn’t making enough “cortisol leftovers” from cortisone [2]. While this test helps distinguish the mechanism of the disorder, the diagnosis is made by integrating these results with your clinical picture, other hormone tests, and sometimes genetics.

Common questions in this guide

What causes apparent cortisone reductase deficiency?
ACRD is linked to changes in the HSD11B1 or H6PD gene. These changes impair the process that converts inactive cortisone into active cortisol, so cortisol is cleared from the body faster than usual.
Why can ACRD cause high androgen levels?
When cortisol is cleared too quickly, the brain increases ACTH signals to the adrenal glands. The adrenal glands work harder and may produce excess androgens and 17-hydroxyprogesterone, which can contribute to early hair growth, irregular periods, or skin problems.
How is ACRD different from non-classic congenital adrenal hyperplasia?
ACRD mainly affects the conversion of cortisone into cortisol, while non-classic congenital adrenal hyperplasia usually limits cortisol production through a different enzyme problem. Because both conditions can raise 17-hydroxyprogesterone, doctors use the clinical picture, hormone testing, urinary steroid results, and sometimes genetic testing to tell them apart.
What does a 24-hour urinary steroid profile show in ACRD?
The test measures cortisol and cortisone breakdown products and compares the amounts of THF plus 5α-THF with THE. A much lower ratio than expected can support ACRD, but the result must be interpreted with other hormone tests and the person's symptoms.
Can someone have both ACRD and polycystic ovary syndrome?
Yes. Polycystic ovaries or symptoms that resemble PCOS do not automatically rule out ACRD, and both conditions can occur together. Doctors may evaluate adrenal hormone production, ovulation, and other findings separately.
Does ACRD mean the body cannot make cortisol?
Not necessarily. In ACRD, the body can usually make cortisol but loses active cortisol too quickly because conversion from cortisone is impaired. This is different from a complete inability to produce cortisol, although the overall hormone pattern still requires specialist evaluation.

Get notified when new evidence is published on Hyperandrogenism due to cortisone reductase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Alterations of Cortisol Metabolism in Human Disorders.

    White PC

    Hormone research in paediatrics 2018; (89(5)):320-330 doi:10.1159/000485508.

    PMID: 29843121
  2. 2

    A follow-up history of young man with apparent cortisone reductase deficiency (ACRD) - several years after diagnosis.

    Zajkowska A, Rydzewska M, Wojtkielewicz K, et al.

    Pediatric endocrinology, diabetes, and metabolism 2017; (23(1)):42-48 doi:10.18544/PEDM-23.01.0073.

    PMID: 29073307
  3. 3

    Assisted Reproduction in Congenital Adrenal Hyperplasia.

    Chatziaggelou A, Sakkas EG, Votino R, et al.

    Frontiers in endocrinology 2019; (10()):723 doi:10.3389/fendo.2019.00723.

    PMID: 31708872
  4. 4

    Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome.

    Dumesic DA, Turcu AF, Liu H, et al.

    Journal of the Endocrine Society 2023; (7(8)):bvad079 doi:10.1210/jendso/bvad079.

    PMID: 37404244
  5. 5

    Face-sparing Congenital Generalized Lipodystrophy Type 1 Associated With Nonclassical Congenital Adrenal Hyperplasia.

    Costa S, Sampaio L, Berta Sousa A, et al.

    The Journal of clinical endocrinology and metabolism 2022; (107(9)):2433-2438 doi:10.1210/clinem/dgac406.

    PMID: 35857714
  6. 6

    Polycystic ovary syndrome in pediatric obesity and diabetes.

    Dondi E, Tufano M, Vigone MC, et al.

    Minerva pediatrics 2021; (73(6)):523-536 doi:10.23736/S2724-5276.21.06542-3.

    PMID: 34286948
  7. 7

    Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome.

    Blumenfeld Z, Kaidar G, Zuckerman-Levin N, et al.

    Clinical medicine insights. Reproductive health 2016; (10()):9-13 doi:10.4137/CMRH.S35567.

    PMID: 27168731
  8. 8

    Estimation of reference curves for the urinary steroid metabolome in the first year of life in healthy children: Tracing the complexity of human postnatal steroidogenesis.

    Dhayat NA, Frey AC, Frey BM, et al.

    The Journal of steroid biochemistry and molecular biology 2015; (154()):226-36.

    PMID: 26297192

This page explains ACRD biology and testing for informational purposes only and does not constitute medical advice. An endocrinologist should interpret your hormone results and decide whether genetic or urinary testing is appropriate for you or your child.